Evidation | Real-World Data Solutions
Real-world data to understand behavior, outcomes, and what happens next
Through direct connections with millions of individuals, Evidation builds longitudinal, multimodal cohorts that support discovery, evidence generation, and commercial decisions by revealing treatment behavior, disease progression, and real-world outcomes over time.
Most real-world data miss how health actually unfolds over time.
Trials fail and therapies go underutilized when decisions rely on episodic data that miss behavior, experience, and change between clinical encounters. Evidation captures longitudinal, multimodal data directly from individuals to reveal treatment behavior, disease progression, and real-world outcomes over time.
Built from the Evidation Community, population cohorts enable continuous data collection, evidence generation, and engagement.
Access deeply characterized populations through one-time engagements or ongoing subscriptions, enabling longitudinal data collection, repeated measurement, and real-time engagement over time.
Identify a population
Access 5 million engaged individuals across 100+ conditions, or define a cohort aligned to your scientific or commercial objective.
Collect multi-modal data
Capture longitudinal, multimodal data directly from individuals — including clinical records, ePROs, and digital signals.
Select modular offerings
Combine data and activation offerings to support research, evidence generation, and commercialization.
Data Offerings
- Real-World Data\
Rich multimodal datasets providing historical context\
Learn more → - Patient Insights\
Understand needs, preferences, and decision drivers\
Learn more → - Prospective Studies\
Sponsor driven observational research\
Learn more →
Activation Offerings
- Recruitment\
Find and enroll the right trial participants\
Learn more → - Activation\
Drive awareness, engagement, and real-world action\
Learn more →
Access data from existing cohorts, or build your own.
Choose from predefined groups of individuals using real-world health labels, or define a custom cohort aligned to your scientific and commercial objectives.
Featured cohorts
- Autoimmune
- Cardiometabolic
- Dermatology
- Migraine
Additional cohorts
- Anxiety
- Asthma
- ADHD
- Depression
- Dyslipidemia
- Endometriosis
- Epilepsy
- Hypertension
- Crohn’s & Ulcerative Colitis
- Irritable Bowel Syndrome
- Insomnia
- PCOS
- Psoriasis
- Sleep Apnea
- Type II Diabetes
- Uterine Fibroids
- Women’s Health
The Evidation Community: an ongoing connection to 5M people
Impact for customers
Life Sciences
- Understand treatment behavior and real-world outcomes
- Identify and segment patient populations
- Generate evidence and support publications
- Track and engage patients longitudinally
Consumer Health
- Understand real-world product usage and behavior
- Segment consumer populations
- Measure product impact over time
- Stay connected to consumers post-purchase
Government
- Accelerate research planning and recruitment
- Engage priority and underserved populations
- Enable longitudinal research
- Monitor health behavior at population scale
Non-Profit
- Accelerate research planning and recruitment
- Engage patient populations
- Enable longitudinal research
Who we work with
Evidation partners include top biopharma companies, as well as consumer health companies, technology companies, non-profit organizations, and government agencies.
Our commitment to privacy, security, and compliance
%201.webp)
See how we drive success for our customers:
Exploring potential to reduce stroke risk with earlier detection of Afib
Evidation partnered with Johnson&Johnson to support a multi-year, observational study that sought to assess whether the Heartline™ Study app on iPhone, and the ECG app and irregular rhythm notification feature on Apple Watch, can reduce the likelihood of stroke and improve health outcomes with earlier detection of atrial fibrillation.
30K+ participants aged 65+
Improving blood pressure in overweight individuals through a digital self-management program
Omada ran a pilot study run managed by Evidation to demonstrate the value of a digital hypertension self-management program by quantifying its impact on blood pressure control. As a result of this study, Omada was able to publish evidence that their app improves blood pressure and medication adherence.
151 individuals with hypertension recruited from the Evidation Community
FluSmart participants receive alerts and nudges to seek care
In partnership with BARDA, Evidation developed and deployed a flu monitoring program, FluSmart, within the Evidation Community to collect rich, longitudinal data and activate high-risk participants into research and care.
200K+ individuals participated in FluSmart
90%+ engagement rate
Helping cardiovascular patients better understand and act on their heart health
The American College of Cardiology (ACC) launched the Heart Health patient engagement program on the Evidation platform to allow patients to track their everyday health and proactively manage their care beyond traditional clinical settings.
33K participants joined the program
87% of individuals who shared their personalized insights report with their care team found it helpful or extremely helpful
Identifying and addressing gaps in the patient experience
Myovant uncovered significant unmet needs among individuals with uterine fibroids (UF) in a direct-to-patient 4-month study with 350 women living with UF.
92% weekly survey completion
85% daily survey completion
Increasing treatment rates with co-created patient engagement
Evidation partnered with Sanofi to test and refine content and messaging for a Type 2 diabetes flu vaccine education program.
10K individuals recruited from the Evidation Community
Up to 2x increase in vaccination rates for participants who engaged with customized diabetes campaign vs. those who engaged with generic messaging
Creating the first large-scale, nationally representative digital health dataset
Evidation partnered with USC and the RAND Corporation on American Life in Real-time (ALiR), a first-of-its-kind, publicly available benchmark registry and research infrastructure for person-generated health data collected from smartphones and wearables to advance equitable precision health.
Digital engagement program launched to more than 1K participants
Developing an early warning algorithm for individuals at high risk for COVID-19
Evidation conducted a study to demonstrate that person-generated health data, including data from smartphones and wearable devices, has the potential to enable applications ranging from individual-level early warnings or population-level hotspot detection for COVID-19.
800+ individuals recruited from the Evidation Community
80% compliance with study activities
Measuring cognitive impairment with direct-from-patient real-world data
Evidation partnered with Eli Lilly to develop new endpoints and identify digital signals of cognitive impairment through the use of digital and wearable devices, mobile apps, and sleep sensors.
16TB of multimodal data collected over 12 weeks
1K+ features extracted from participant behaviorgrams
Better Understanding of the Metamorphosis of Pregnancy (BUMP)
Evidation partnered with 4YouandMe to provide a platform to manage data collection, processing, and storage for the BUMP longitudinal feasibility study aimed to gain a deeper understanding of the pre-pregnancy and pregnancy symptom experience using digital tools.
1K participants targeted for enrollment onto the platform
Developing more successful digital health programs with patient perspectives
Evidation partnered with Sanofi to get data-driven insights to prioritize program features and future development of a connected ecosystem for managing type 2 diabetes (T2D).
114 insulin-dependent adults with T2D recruited from the Evidation community
Recruitment completed in 3 weeks